Epicrispr Bio

Developer of therapeutics for multiple disease

placeSan Francisco, California, United States calendar_todayFounded 2018 language epicrispr.com

Registered entities

Social engagement

Social engagement: 6.5K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Ally Bridge Group.

Investor typeCountShare
Venture capital133%
Private equity133%
Other / undisclosed133%
Coming soon